Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
Main Authors: | Tomonaga Masao, Uozumi Kimiharu, Tsukasaki Kunihiro, Uike Naokuni, Ishida Takashi, Yamamoto Kazuhito, Tobinai Kensei, Utsunomiya Atae, Ueda Ryuzo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | Retrovirology |
Similar Items
-
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors
by: Kaoru Fujikawa, et al.
Published: (2023-01-01) -
Integrated analysis of phase 1a and 1b randomized controlled trials; Treg-targeted cancer immunotherapy with the humanized anti-CCR4 antibody, KW-0761, for advanced solid tumors.
by: Kaoru Fujikawa, et al.
Published: (2023-01-01) -
Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level
by: Choi Ilseung, et al.
Published: (2011-06-01) -
Quantitatively immunological characterization of mogamulizumab skin disorders in ATL patients
by: Asahi Ito, et al.
Published: (2019-08-01) -
On the Complexity of ATL and ATL* Module Checking
by: Laura Bozzelli, et al.
Published: (2017-09-01)